Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
European Journal of Pharmacology|April 21, 2005
Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in miceFabrício A Moreira, Francisco S Guimarães
European Journal of Pharmacology|November 21, 2007
Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in miceJuliana V Leite, Francisco S Guimarães, Fabricio A Moreira
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 1, 2006
Anxiolytic-like effect of cannabidiol in the rat Vogel conflict testFabrício A Moreira, Daniele C Aguiar, Francisco S Guimarães
The International Journal of Neuropsychopharmacology|December 19, 2014
Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophreniaFelipe V Gomes, Francisco S Guimarães, Anthony A Grace
Schizophrenia Bulletin Open|December 3, 2025
Protective Effects of N-Acetylcysteine Against Schizophrenia-Related Behavioral and Parvalbumin Interneuron Deficits Induced by Adolescent StressÍcaro S Freitas, Francisco S Guimarães, Felipe V Gomes
Acta Neuropsychiatrica|August 5, 2021
DNA methylation in stress and depression: from biomarker to therapeuticsAmanda J Sales, Francisco S Guimarães, Sâmia R L Joca
Vitamins and Hormones|August 4, 2009
Endocannabinoid system and fear conditioningLeonardo B M Resstel, Fabrício A Moreira, Francisco S Guimarães
Pageof 17